60 related articles for article (PubMed ID: 19140919)
1. Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates.
Tao S; Ashikaga H; Ciuffo LA; Yoneyama K; Lima JAC; Frank TF; Weiss RG; Tomaselli GF; Wu KC
J Cardiovasc Electrophysiol; 2017 Jul; 28(7):796-805. PubMed ID: 28429529
[TBL] [Abstract][Full Text] [Related]
2. Retracted: T-peak to T-end Interval Predicts Appropriate Shocks in Patients with Heart Failure Undergoing Implantable Cardioverter Defibrillator Implantation for Primary Prophylaxis.
Sen Ö; Yilmaz S; Sen F; Balcı KG; Akboga MK; Yayla C; Özeke Ö
Ann Noninvasive Electrocardiol; 2024 Jan; 29(1):. PubMed ID: 27265779
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Autonomic Dysfunction and Incidence of
Wessel N; Berg K; Kraemer JF; Gapelyuk A; Rietsch K; Hauser T; Kurths J; Wenzel D; Klein N; Kolb C; Belke R; Schirdewan A; Kääb S
Front Physiol; 2020; 11():596844. PubMed ID: 33363477
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients.
Simsek H; Sahin M; Akyol A; Akdag S; Ozkol HU; Gumrukcuoglu HA; Gunes Y
ScientificWorldJournal; 2013; 2013():901215. PubMed ID: 23653531
[TBL] [Abstract][Full Text] [Related]
5. Catheter ablation of atrial arrhythmias to prevent ventricular tachycardia in a patient with mobile left ventricular thrombus.
Patel AS; Cronin EM
HeartRhythm Case Rep; 2021 Oct; 7(10):687-690. PubMed ID: 34712566
[No Abstract] [Full Text] [Related]
6. Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias.
Behnes M; Rusnak J; Taton G; Schupp T; Reiser L; Bollow A; Reichelt T; Engelke N; Ellguth D; Kuche P; Ibrahim El-Battrawy ; Lang S; Nienaber CA; Mashayekhi K; Akin M; Bertsch T; Ferdinand D; Weiss C; Borggrefe M; Akin I
Sci Rep; 2019 Oct; 9(1):14291. PubMed ID: 31582805
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
Kato S; Foppa M; Roujol S; Basha T; Berg S; Kissinger KV; Goddu B; Manning WJ; Nezafat R
Int J Cardiol; 2016 Jan; 203():848-54. PubMed ID: 26599750
[TBL] [Abstract][Full Text] [Related]
8. Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data.
Botto GL; Luzi M; Ruffa F; Russo G; Ferrari G
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S48-53. PubMed ID: 17169133
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillators and their role in heart failure progression.
Cevik C; Perez-Verdia A; Nugent K
Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
[TBL] [Abstract][Full Text] [Related]
10. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
[TBL] [Abstract][Full Text] [Related]
11. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Smit MD; Van Dessel PF; Rienstra M; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Veldhuisen DJ; Van Gelder IC
Europace; 2006 Aug; 8(8):566-72. PubMed ID: 16864611
[TBL] [Abstract][Full Text] [Related]
13. Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy.
Bhavnani SP; Coleman CI; White CM; Clyne CA; Yarlagadda R; Guertin D; Kluger J
Europace; 2008 Jul; 10(7):854-9. PubMed ID: 18495672
[TBL] [Abstract][Full Text] [Related]
14. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
15. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
